Form 4: Amedisys Director Receives Stock Award
SEC Form 4 Filing
Director Molly Joel Coye received 1,678 restricted stock units from Amedisys Inc. on May 3, 2024, which will vest on May 3, 2025, contingent upon continued service on the board.
Summary
- Molly Joel Coye, a director of Amedisys Inc., received 1,678 time-based Restricted Stock Units (RSUs) on May 3, 2024.
- Each RSU represents a contingent right to receive one share of Amedisys' common stock.
- The RSUs will vest 100% on May 3, 2025, provided Coye continues to serve as a non-employee member of the Issuer's Board of Directors through the vesting date.
- Following the transaction, Coye beneficially owns 7,128 shares of Amedisys common stock.
Sentiment
Score: 7
Explanation: The document reflects a standard corporate governance practice of awarding stock to directors, which is generally viewed positively as it aligns interests with shareholders. There are no indications of negative sentiment.
Positives
- The stock award aligns the director's interests with those of the shareholders, incentivizing continued service and contribution to the company's success.
Future Outlook
The director's continued service is tied to the vesting of the stock award, suggesting an ongoing commitment to the company.
Industry Context
Stock awards are a common form of compensation for directors, aligning their interests with shareholders and incentivizing long-term value creation. This is a standard practice in corporate governance.
Comparison to Industry Standards
- Director compensation packages often include a mix of cash and equity, with equity awards like RSUs becoming increasingly common.
- Companies like UnitedHealth Group and Humana also use equity-based compensation for their directors to align their interests with shareholders.
- The size of the award is typical for non-executive directors in similar-sized healthcare companies.
Stakeholder Impact
- Shareholders may view the stock award positively as it aligns the director's interests with the company's long-term performance.
Key Dates
| Date | Description |
|---|---|
| 05/03/2024 | Date of transaction: Molly Joel Coye received 1,678 Restricted Stock Units. |
| 05/03/2025 | Vesting date for the Restricted Stock Units, contingent upon continued service. |
| 05/07/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.